The effects of biosynthetic insulin-like growth factor-1 supplementation on somatic growth, maturation, and erythropoiesis on the neonatal rat

Anthony F Philipps, B. Persson, K. Hall, M. Lake, A. Skottner, T. Sanengen, V. R. Sara

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Somatomedins are anabolic hormones that may stimulate growth during the perinatal period. To test this hypothesis, neonatal rats were injected with a biosynthetic somatomedin, insulin-like growth factor 1 (IGF-1) twice daily for the first 2 wk of life. Two biosynthetic IGF-1 preparations of different potency were tested as well as a preparation of human growth hormone in five litters of rats. When compared to saline-injected rats, IGF-1 injected rats had increased body weight and tail lengths as well as specific increases in weights of liver, brain, heart, and testes. In addition, significant increases in bone marrow erythropoietic cell precursors were apparent after IGF-1 injection. IGF-1-treated neonatal rats also exhibited precocious eye opening as a sign of epithelial cell differentiation. Five additional litters of rats received similar injections but were exposed to postnatal nutritional deprivation via artificially increasing litter size. Although IFG-1 caused stimulation of bone marrow erythropoiesis and precocious eye opening, no effects of IGF-1 on somatic or organ growth could be documented. This represents the first demonstration in vivo of the anabolic effects of IGF-1 in rapidly growing neonatal rats but suggests that nutritional sufficiency may also be necessary for the full expression of somatomedin effects.

Original languageEnglish (US)
Pages (from-to)298-305
Number of pages8
JournalPediatric Research
Volume23
Issue number3
StatePublished - 1988
Externally publishedYes

Fingerprint

Erythropoiesis
Somatomedins
Growth
Anabolic Agents
Litter Size
Injections
Human Growth Hormone
Bone Marrow Cells
Tail
Testis
Cell Differentiation
Bone Marrow
Epithelial Cells
Body Weight
Hormones
Weights and Measures
Liver
Brain

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

The effects of biosynthetic insulin-like growth factor-1 supplementation on somatic growth, maturation, and erythropoiesis on the neonatal rat. / Philipps, Anthony F; Persson, B.; Hall, K.; Lake, M.; Skottner, A.; Sanengen, T.; Sara, V. R.

In: Pediatric Research, Vol. 23, No. 3, 1988, p. 298-305.

Research output: Contribution to journalArticle

Philipps, Anthony F ; Persson, B. ; Hall, K. ; Lake, M. ; Skottner, A. ; Sanengen, T. ; Sara, V. R. / The effects of biosynthetic insulin-like growth factor-1 supplementation on somatic growth, maturation, and erythropoiesis on the neonatal rat. In: Pediatric Research. 1988 ; Vol. 23, No. 3. pp. 298-305.
@article{251147b194e049c9a6e03c4dd1ff8ce5,
title = "The effects of biosynthetic insulin-like growth factor-1 supplementation on somatic growth, maturation, and erythropoiesis on the neonatal rat",
abstract = "Somatomedins are anabolic hormones that may stimulate growth during the perinatal period. To test this hypothesis, neonatal rats were injected with a biosynthetic somatomedin, insulin-like growth factor 1 (IGF-1) twice daily for the first 2 wk of life. Two biosynthetic IGF-1 preparations of different potency were tested as well as a preparation of human growth hormone in five litters of rats. When compared to saline-injected rats, IGF-1 injected rats had increased body weight and tail lengths as well as specific increases in weights of liver, brain, heart, and testes. In addition, significant increases in bone marrow erythropoietic cell precursors were apparent after IGF-1 injection. IGF-1-treated neonatal rats also exhibited precocious eye opening as a sign of epithelial cell differentiation. Five additional litters of rats received similar injections but were exposed to postnatal nutritional deprivation via artificially increasing litter size. Although IFG-1 caused stimulation of bone marrow erythropoiesis and precocious eye opening, no effects of IGF-1 on somatic or organ growth could be documented. This represents the first demonstration in vivo of the anabolic effects of IGF-1 in rapidly growing neonatal rats but suggests that nutritional sufficiency may also be necessary for the full expression of somatomedin effects.",
author = "Philipps, {Anthony F} and B. Persson and K. Hall and M. Lake and A. Skottner and T. Sanengen and Sara, {V. R.}",
year = "1988",
language = "English (US)",
volume = "23",
pages = "298--305",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - The effects of biosynthetic insulin-like growth factor-1 supplementation on somatic growth, maturation, and erythropoiesis on the neonatal rat

AU - Philipps, Anthony F

AU - Persson, B.

AU - Hall, K.

AU - Lake, M.

AU - Skottner, A.

AU - Sanengen, T.

AU - Sara, V. R.

PY - 1988

Y1 - 1988

N2 - Somatomedins are anabolic hormones that may stimulate growth during the perinatal period. To test this hypothesis, neonatal rats were injected with a biosynthetic somatomedin, insulin-like growth factor 1 (IGF-1) twice daily for the first 2 wk of life. Two biosynthetic IGF-1 preparations of different potency were tested as well as a preparation of human growth hormone in five litters of rats. When compared to saline-injected rats, IGF-1 injected rats had increased body weight and tail lengths as well as specific increases in weights of liver, brain, heart, and testes. In addition, significant increases in bone marrow erythropoietic cell precursors were apparent after IGF-1 injection. IGF-1-treated neonatal rats also exhibited precocious eye opening as a sign of epithelial cell differentiation. Five additional litters of rats received similar injections but were exposed to postnatal nutritional deprivation via artificially increasing litter size. Although IFG-1 caused stimulation of bone marrow erythropoiesis and precocious eye opening, no effects of IGF-1 on somatic or organ growth could be documented. This represents the first demonstration in vivo of the anabolic effects of IGF-1 in rapidly growing neonatal rats but suggests that nutritional sufficiency may also be necessary for the full expression of somatomedin effects.

AB - Somatomedins are anabolic hormones that may stimulate growth during the perinatal period. To test this hypothesis, neonatal rats were injected with a biosynthetic somatomedin, insulin-like growth factor 1 (IGF-1) twice daily for the first 2 wk of life. Two biosynthetic IGF-1 preparations of different potency were tested as well as a preparation of human growth hormone in five litters of rats. When compared to saline-injected rats, IGF-1 injected rats had increased body weight and tail lengths as well as specific increases in weights of liver, brain, heart, and testes. In addition, significant increases in bone marrow erythropoietic cell precursors were apparent after IGF-1 injection. IGF-1-treated neonatal rats also exhibited precocious eye opening as a sign of epithelial cell differentiation. Five additional litters of rats received similar injections but were exposed to postnatal nutritional deprivation via artificially increasing litter size. Although IFG-1 caused stimulation of bone marrow erythropoiesis and precocious eye opening, no effects of IGF-1 on somatic or organ growth could be documented. This represents the first demonstration in vivo of the anabolic effects of IGF-1 in rapidly growing neonatal rats but suggests that nutritional sufficiency may also be necessary for the full expression of somatomedin effects.

UR - http://www.scopus.com/inward/record.url?scp=0023856430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023856430&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 298

EP - 305

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 3

ER -